The toilet seat, which is not FDA approved yet, will be issued to heart failure patients after leaving the hospital. Designed to measure the heart’s electrical and mechanical activity, the toilet seat can monitor heart rate, blood pressure, blood oxygenation levels and the individual’s weight and stroke volume.
Once the biometrics are collected, algorithms are used to analyze the data. Researchers plan to add a function that will alert health providers of a deteriorating condition while the patient is asymptomatic, prompting providers to approach interventions like a prescription change sooner to avoid hospital readmission.
Human-subject testing and pre-clinical studies have begun, and researchers are currently writing grants for additional funding.
More articles on health IT:
Walmart to lose its chief technology officer shortly after labeling itself tech company
277,000 patients affected in Zoll data breach
Amazon unveils its 1st skincare line
